Myelin oligodendrocyte glycoprotein antibody disease
- G37.81 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- ICD-10-CM G37.81 is a new 2024 ICD-10-CM code that became effective on October 1, 2023.
- This is the American ICD-10-CM version of G37.81 – other international versions of ICD-10 G37.81 may differ.
Applicable To
- MOG antibody disease
Code Also
- associated manifestations, if known, such as:
- noninfectious acute disseminated encephalomyelitis (G04.81)
- neuromyelitis optica (G36.0)
The following code(s) above G37.81 contain annotation back-references
that may be applicable to G37.81:
- G00-G99 Diseases of the nervous system
ICD-10-CM G37.81 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):
- 058 Multiple sclerosis and cerebellar ataxia with mcc
- 059 Multiple sclerosis and cerebellar ataxia with cc
- 060 Multiple sclerosis and cerebellar ataxia without cc/mcc
Code History
- 2024 (effective 10/1/2023): New code
Diagnosis Index entries containing back-references to G37.81:
- Disease, diseased – see also Syndrome
- MOG antibody G37.81
- myelin oligodendrocyte glycoprotein antibody G37.81
- MOGAD G37.81 (myelin oligodendrocyte glycoprotein antibody disease)